Homepage

The BOSTON-1 and BOSTON-2 are Phase III studies designed to evaluate the safety and efficacy of investigational Liposomal Cyclosporine A (L-CsA-i) in patients with bronchiolitis obliterans syndrome (BOS) following a single or double lung transplant.
Study Overview
Study Overview
Lungs
About BOS
Stethoscope
About Clinical Trials
Locator Icon
Study Centers
Legal popup

This page is for US healthcare professionals only.

Are you a US healthcare professional?